Addition of Local Hepatic Therapy to Sorafenib in Patients With Advanced Hepatocellular Carcinoma (Stage BCLC C)

Digestion - Switzerland
doi 10.1159/000367686
Full Text
Abstract

Available in full text

Date
Authors
Publisher

S. Karger AG

Related search

Sorafenib Combined With Hepatectomy in Patients With Intermediate-Stage and Advanced Hepatocellular Carcinoma

Archives of Medical Science
Medicine
2017English

Attenuation of Liver Stiffness in Sorafenib-Treated Patients With Advanced Hepatocellular Carcinoma

Hepatoma Research
2017English

Sorafenib Alone Versus Sorafenib Combined With Transarterial Chemoembolization for Advanced-Stage Hepatocellular Carcinoma: Results of Propensity Score Analyses

Radiology
Nuclear MedicineRadiologyImaging
2013English

Transcatheter Arterial Chemoembolization After Stopping Sorafenib Therapy for Advanced Hepatocellular Carcinoma

PLoS ONE
Multidisciplinary
2017English

Sorafenib vs Nivolumab in Patients With Hepatocellular Carcinoma

Journal of Liver Research, Disorders & Therapy
2017English

Effect of Body Composition on Survival Benefit of Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma: A Comparison With Sorafenib Therapy

PLoS ONE
Multidisciplinary
2019English

Early Α-Fetoprotein Response Predicts Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib

Journal of Hepatocellular Carcinoma
2015English

Sorafenib-Induced Acute Interstitial Pneumonia in Patients With Advanced Hepatocellular Carcinoma: Report of Three Cases

Clinical Journal of Gastroenterology
MedicineGastroenterology
2012English

A Complete Response Induced by 21-Day Sorafenib Therapy in a Patient With Advanced Hepatocellular Carcinoma

Internal Medicine
Internal MedicineMedicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy